A Novel Strategy for Screening Active Components in Cistanche tubulosa Based on Spectrum-Effect Relationship Analysis and Network Pharmacology

Table 2

Comparison of contents of main components (n = 11).

Components	HM	WE	HR
Geniposidic acid (mg/g)	1.52 ± 2.17^c	1.9 ± 2.45^a	0.32 ± 0.2
Echinacoside (mg/g)	22.47 ± 20.9	28.47 ± 36.2	9.2 ± 7.64^a
Verbascoside (mg/g)	3.97 ± 2.16^c	2.32 ± 1.73^a	0.87 ± 0.57^b
Tubuloside A (mg/g)	1.64 ± 1.68	1.24 ± 1.92	0.7 ± 0.81^a
Isoacteoside (mg/g)	0.79 ± 0.45	3.4 ± 3.46	1.06 ± 0.83

^aindicates versus HM, ^bindicates versus HM, and ^cindicates versus WE.